Literature DB >> 12468310

Double-blind evaluation of two commercial hypoallergenic diets in cats with adverse food reactions.

M Leistra1, T Willemse.   

Abstract

The aim of this study was to evaluate two commercially available selected-protein-source diets as maintenance diets in cats with dermatological manifestations of adverse food reactions. Twenty cats with a confirmed adverse food reaction were tested in a double-blind manner. An adverse food reaction was diagnosed when, after recovery with a home-cooked elimination diet, the signs relapsed after a challenge with their previous dietary components, and re-disappeared on a second elimination diet period. Hereafter the cats were blind and randomly challenged with two commercial hypoallergenic diets. Relapse of the clinical signs was seen in eight cats (40%) on a lamb and rice diet and in 13 cats (65%) on a chicken and rice diet (P>0.05). Neither one of the commercial diets was as effective in controlling the skin problems as the home-cooked elimination diet. The study confirms that commercial hypoallergenic diets are adequate for maintenance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468310     DOI: 10.1053/jfms.2001.0193

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  3 in total

1.  Critically appraised topic on adverse food reactions of companion animals (6): prevalence of noncutaneous manifestations of adverse food reactions in dogs and cats.

Authors:  Ralf S Mueller; Thierry Olivry
Journal:  BMC Vet Res       Date:  2018-11-12       Impact factor: 2.741

Review 2.  Critically appraised topic on adverse food reactions of companion animals (7): signalment and cutaneous manifestations of dogs and cats with adverse food reactions.

Authors:  Thierry Olivry; Ralf S Mueller
Journal:  BMC Vet Res       Date:  2019-05-09       Impact factor: 2.741

3.  The usefulness of a hydrolysed fish and rice starch elimination diet for the diagnosis of adverse food reactions in cats: an open clinical trial.

Authors:  Chiara Noli; Giorgia Beltrando
Journal:  Vet Dermatol       Date:  2021-05-25       Impact factor: 1.589

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.